Search Results

Displaying Results 1-1 of 1 "'VSTM'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors

Jan 30, 2026, 10:19 ET $668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors

decades. This regulatory tailwind places Oncolytics Biotech Inc. (NASDAQ: ONCY), Pfizer (NYSE: PFE), Verastem Oncology (NASDAQ: VSTM), Perspective Therapeutics (NYSE-A: CATX), and RenovoRx (NASDAQ: RNXT) directly at the intersection of pivotal execution and breakthrough

More news about: USA News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.